ZFIN ID: ZDB-FISH-150901-13677
Fish name: WT + MO1-cdx4
Genotype: WT
Targeting Reagent: MO1-cdx4
HUMAN DISEASE MODELED by WT + MO1-cdx4
No data available
GENE EXPRESSION
Gene expression in WT + MO1-cdx4
RNA expression
Expressed Gene Structure Conditions Figures
aldh1a2 standard conditions Fig. 5 with imageFig. S1 with image from Shimizu et al., 2006
cyp26a1 standard conditions Fig. 5 with imageFig. S1 with image from Shimizu et al., 2006
drl standard conditions Fig. 4 with image from Paik et al., 2013
egr2b standard conditions Fig. 1 with image from Skromne et al., 2007
Fig. 2 with imageFig. 5 with image from Shimizu et al., 2006
fgf3 standard conditions Fig. 5 with image from Shimizu et al., 2006
fgf8a standard conditions Fig. 5 with imageFig. S1 with image from Shimizu et al., 2006
fli1 standard conditions Fig. 4 with image from Paik et al., 2013
gata1a standard conditions Fig. S5 from Ro et al., 2011
hbbe3 standard conditions Fig. 2 from Davidson et al., 2003
hoxa9a standard conditions Fig. 5 from Davidson et al., 2003
hoxb6b standard conditions Fig. 5 from Davidson et al., 2003
hoxb7a standard conditions Fig. 5 from Davidson et al., 2003
ins chemical treatment: all-trans-retinoic acid Fig. 7 with image from Kinkel et al., 2008
isl1 standard conditions Fig. 1 with image from Skromne et al., 2007
myod1 standard conditions Fig. 4 with image from Paik et al., 2013
olig2 standard conditions Fig. 1 with image from Skromne et al., 2007
pax2a standard conditions Fig. 4 with image from Paik et al., 2013
Fig. S5 from Ro et al., 2011
tbx16 standard conditions Fig. 4 with image from Paik et al., 2013
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in WT + MO1-cdx4
Phenotype Conditions Figures
hindbrain increased length, abnormal standard conditions Fig. 1 with image from Skromne et al., 2007
hindbrain-spinal cord boundary formation disrupted, abnormal standard conditions Fig. 1 with image from Skromne et al., 2007
insulin secreting cell mislocalised anteriorly, abnormal chemical treatment: all-trans-retinoic acid Fig. 7 with image from Kinkel et al., 2008
insulin secreting cell mislocalised posteriorly, abnormal chemical treatment: all-trans-retinoic acid Fig. 7 with image from Kinkel et al., 2008
post-vent region decreased length, abnormal standard conditions Fig. 2 from Ro et al., 2011
post-vent region decreased size, abnormal standard conditions Table 2 from Shimizu et al., 2005
post-vent region has fewer parts of type somite, abnormal standard conditions Table 2 from Shimizu et al., 2005
post-vent region kinked, abnormal standard conditions Fig. 2 from Ro et al., 2011
post-vent region truncated, abnormal standard conditions Table 2 from Shimizu et al., 2005
regulation of endodermal cell fate specification disrupted, abnormal chemical treatment: all-trans-retinoic acid Fig. 7 with image from Kinkel et al., 2008
spinal cord decreased length, abnormal standard conditions Fig. 1 with image from Skromne et al., 2007

CITATIONS  (8)